Complement C3c Antikörper (FITC)

Produktnummer ABIN458597

Es sind 2+ Publikationen für dieses Produkt verfügbar. Der Ziege Polyklonal anti-Complement C3c Antikörper wird verwendet zum Nachweis von Complement C3c in Proben von Kaninchen. Er wurde validiert für ELISA, ICC, IHC (fro) und IFA.

Kurzübersicht für Complement C3c Antikörper (FITC) (ABIN458597)

Target: Complement C3c (C3C) (Complement Component C3c (C3C))

Reaktivität: Kaninchen

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser Complement C3c Antikörper ist konjugiert mit FITC

Applikation: ELISA, Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Indirect Immunofluorescence Assay (IFA)

Produktdetails anti-Complement C3c Antikörper (FITC)

Verwendungszweck: Goat anti Rabbit C3c, conjugated with FITC

Spezifität: Fluorescein isothiocyanate-conjugated IgG fraction of polyclonal Goat antiSerum to C3c fragment of Rabbit complement factor C3.

Kreuzreaktivität (Details): The antiSerum does not cross-react with any other component of Rabbit plasma. Inter-species crossreactivity is a normal feature of antibodies to plasma proteins since they frequently share antigenic determinants. Cross-reactivity of this antiSerum has not been tested in detail.

Produktmerkmale: In immunoelectrophoresis against fresh rabbit serum, a single precipitin line is obtained in the beta-1 region representing native C3. Against serum containing partly activated C3, a precipitin line is obtained which extends from the beta-1 into the alpha-2 region, demonstrating a gradient. In old serum containing totally activated C3 a single precipitin line in the alpha-2 region is obtained. Antisera to C3c can also react with the fragments C3b, C3bi and smaller fragments, since they all carry antigenic determinants of the C3c domain. The product does not react with any other proteins component of rabbit serum or plasma. The fluorescent immunoconjugate to rabbit C3c is used to determine the presence and pattern of C3 in tissue lesions using immunohistochemical staining techniques. Locally deposited immune complexes in tissue usually contain complement, pointing to activation of the classical pathway. Complement activation in vivo implies active disease and may contribute to the elicitation of the pathogenesis and he extent of tissue destruction. Sometimes the diagnosis can be based on directly on laboratory findings. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal.

Aufreinigung: Purified IgG fraction from antiserum

Immunogen: C3c is the major fragment resulting from C3 cleavage by C3 convertase and factor I. It is composed of an intact beta chain bound to two fragments of the alpha chain. C3c is isolated and purified from pooled normal rabbit serum. Freund's complete adjuvant is used in the first step of the immunization procedure. Freund's complete adjuvant is used in the first step of the immunization procedure.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA,Immunocytochemistry,Immunohistochemistry (frozen),(In)direct immunofluorescence.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: It is reconstituted by adding 1 mL sterile distilled water, spun down to remove insoluble particles, divided into small aliquots, frozen and stored at or below -20 °C.

Buffer: Fluorochrome-coupled purified hyperimmune IgG lyophilized from a solution in phosphate buffered saline (PBS, pH 7.2) No preservative added, as it may interfere with the antibody activity.

Konservierungsmittel: Without preservative

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: The lyophilized conjugate is shipped at ambient temperature and may be stored at +4°C, prolonged storage at or below -20°C. Prior to use, an aliquot is thawed slowly at ambient temperature, spun down again and used to prepare working dilutions by adding sterile phosphate buffered saline (PBS, pH 7.2). Repeated thawing and freezing should be avoided. Working dilutions should be stored at +4°C, not refrozen, and preferably used the same day. If a slight precipitation occurs upon storage, this should be removed by centrifugation. It will not affect the performance of the product.

Referenzen für anti-Complement C3c Antikörper (FITC) (ABIN458597)

O'Donnell, Henderson, Anhalt, Fusco, Erasmus, Lambe, Marzi: "Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model." in: International journal of molecular sciences, Vol. 25, Issue 15, (2024) (PubMed).

ODonnell, Feldmann, Kaza, Clancy, Hanley, Fletcher, Marzi: "Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine." in: EBioMedicine, Vol. 89, pp. 104463, (2023) (PubMed).

Details zu Complement C3c

Target: Complement C3c (C3C) (Complement Component C3c (C3C))

Andere Bezeichnung: C3c Fragment of Complement Factor C3

UniProt: P12247